Brain MRI synthesis in 3D across T1w, T2w, FLAIR and SWI, whole-brain or skull-stripped, at up to 512x512x256 voxels in 30 sampling steps.
No providers recorded yet. Browse all providers
A brain MRI examination is never one image. T1-weighted volumes carry anatomy, FLAIR isolates white-matter lesions, T2 shows fluid and edema, and susceptibility-weighted imaging reveals microbleeds — and which of those a site acquires, in which plane, is a matter of local protocol. Anyone assembling a training cohort for brain segmentation or lesion detection therefore inherits a ragged matrix: thousands of one contrast, a handful of another, and no way to fill the holes short of scanning more patients.
NV-Generate-MR-Brain generates the missing volumes. It is the brain-specific checkpoint
(rflow-mr-brain) of NVIDIA's NV-Generate-CTMR family, released in March 2026 by
NVIDIA with the University of Zurich,
Istanbul Medipol University and
Forithmus. It carries over the rectified-flow latent generative
recipe that MAISI-v2 introduced for CT — itself the successor to the
1000-step DDPM used by MAISI — and trains it on brain MRI alone.
That specialization is what separates it from its sibling NV-Generate-MR, which spans prostate, breast, abdomen and brain and whose documentation recommends fine-tuning on your own data for a new anatomy. Because every training volume here is a head, the brain checkpoint doubles the through-plane extent to 512x512x256 voxels at 0.45x0.45x0.7 mm, adds susceptibility-weighted imaging to the contrast vocabulary, extends skull-stripped output — which the general model offers for FLAIR alone — to every contrast, and is the variant NVIDIA's own guide tells brain users to prefer.
The generator is a 240M-parameter 3D UNet with attention blocks operating in the latent space
of a variational autoencoder shared with the CT checkpoints, so the diffusion model never
touches full-resolution voxels. Unlike the paired ddpm-ct variant it takes no body-region
input — the anatomy is fixed — and conditions only on the modality code. Training used the
MR-RATE brain corpus assembled by Forithmus, the University of Zurich and Istanbul Medipol
University: the model card reports roughly 28,000 scans for training with about 8,000 held out
for testing and 4,000 for evaluation, while the repository's field-of-view tables tally
318,825 unique source volumes across contrast and plane, each preprocessed in both whole-brain
and skull-stripped form. That 318,825 is a floor rather than a training-set size — the table
covers axial, sagittal and coronal acquisitions only, and excludes the oblique scans the guide
says the model also trained on. A third figure sits alongside both: NVIDIA's data
documentation describes a successor checkpoint trained on 73,516 subjects and 665,371 scans,
though the shipped configs and download script still fetch the v0 weights described here.
Coverage is uneven by design of the source clinic — sagittal T1 and FLAIR dominate,
while the guide flags sagittal and coronal SWI, and MRA in any plane, as too sparse for
reliable output. NVIDIA has published no image-quality benchmark for this checkpoint; the
repository's FID comparison covers the CT variants only.
The immediate use is data augmentation where real brain MRI is scarce or unshareable: enlarging cohorts for segmentation and lesion-detection training, generating the contrast a retrospective study lacks, or producing volumes that carry no patient identity for distribution across institutions. The skull-stripped output feeds downstream tools that expect brain-extracted input without an extra preprocessing stage, and the per-plane field-of-view control makes it practical to stress-test an imaging pipeline against acquisition geometries a single site never produces.
NV-Generate-MR-Brain extends an openly licensed synthetic-imaging family from CT into neuroimaging, and its weights carry the NVIDIA Open Model License, which permits commercial use — a materially different footing from the non-commercial terms on its general MR sibling. That permission covers the weights, not their provenance: MR-RATE itself is CC BY-NC-SA 4.0, and its publishers direct commercial inquiries to the dataset owners rather than granting them in the licence. The honest limits are worth stating: it is a version 0.1 research artifact, explicitly not a clinically validated device; the cross-modality synthesis the model card names as its primary use case (T1 to FLAIR and back) is not shipped, and unconditional single-contrast generation is what works today; and asking for a field of view outside the training distribution yields unusable volumes rather than a warning.
Much of this page is generated or calculated automatically. Flag anything that looks off and we will re-run it.